{"tid":2511565,"cid":5,"subCid":10,"title":"世衛尚在考慮是否批國藥和科興緊急使用","createTime":"2021-05-01T04:22:06.000Z","updateTime":"2021-05-01T04:22:06.000Z","uid":21470,"like":0,"dislike":0,"uniUserReply":1,"replies":[{"pid":"c74987a4c59c5fb120040e5d61beac1a33c3259f","tid":2511565,"uid":21470,"like":0,"dislike":0,"score":0,"citedBy":0,"replyTime":"2021-05-01T04:22:06.000Z","msg":"世衛認可緊急使用莫德納新冠疫苗<br />\n<br />\n世界衛生組織認可緊急使用美國藥廠莫德納的新冠疫苗，是第五款獲世衛認可的新冠疫苗。作為世衛分配疫苗機制主要來源地的印度，因應疫情不斷升溫，限制疫苗出口，影響全球供應，世衛表示，現時批准更多疫苗上市，是十分重要。<br />\n<br />\n莫德納疫苗同BioNTech疫苗一樣，都是mRNA疫苗。莫德納本周宣布計劃擴大生產網絡，期望明年能提高產量至30億劑。<br />\n<br />\n至於中國的國藥和科興疫苗，世衛尚在考慮會否列作緊急使用，預料下周完結前會作出決定。<br />\n<br />\n原文網址：<a href=\"https://www.881903.com/news/international/2389700\" data-sr-url=\"https://r.lihkg.com/link?u=https%3A%2F%2Fwww.881903.com%2Fnews%2Finternational%2F2389700&d=TdbSzDXFtRyzmt3f81zqRBn9kyGvuUmJUtyTBy059fc%3D&h=b0d2aeb1\" data-auto-link target=\"_blank\">https://www.881903.com/news/international/2389700</a>"}]}